+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating a one-year version of the Parent-Child Assistance Program PCAP-1, a home visitation and case management program designed to support parents who have used substances during pregnancy or postpartum. The study aims to assess PCAP-1s effectiveness in preventing foster care placement, promoting family reunification, supporting parent recovery, and connecting parents to community resources. This evaluation addresses a knowledge gap by focusing on a vulnerable population with high child welfare involvement and substance use challenges. Participants in the treatment group will receive PCAP-1 services for one year, involving biweekly meetings with trained case managers either in the home or community settings. Case managers help parents set personal goals, provide support, and connect them with tailored resources. The control group will include parents matched from administrative data who receive usual community services but not PCAP. The program adaptation to one year aligns with federal funding timelines and may better fit families involved in child welfare. During the study, participants will complete self-administered surveys at baseline, 12 months, and 18 months to capture behaviors and social factors related to addiction and family well-being. Case managers will submit regular reports on client progress, including substance use, child custody, and service connections. Administrative child welfare data will provide detailed information on foster care placements and reunifications. The study will measure outcomes such as the proportion of children not placed in foster care and parents maintaining custody after one year, along with secondary outcomes related to housing, employment, education, public benefits, and criminal justice involvement. Participation spans up to 18 months with ongoing monitoring.

Age: 18Years +All GendersPhase Not Applicable
2 locations
M

Actively Recruiting

Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.

Age: 18Years +All Genders
2393 locations
C

Actively Recruiting

This trial investigates the safety and effectiveness of two head lice treatments Elimax Green Lotion Emogreen and Walgreens Lice Killing Shampoo. It includes individuals aged 6 months and older who have confirmed head lice infestations. The research focuses on comparing how well these products work and their safety, including monitoring for skin and eye irritation and any adverse events during the study. Participants are randomly assigned to one of two groups one group receives the Elimax Green Lotion with Emogreen, a device-based treatment that physically suffocates lice using bio-alkane and beeswax, combined with a lice comb the other group receives Walgreens Lice Killing Shampoo containing Piperonyl Butoxide and Pyrethrum Extract. The treatments are applied to dry hair, left on for 10 minutes, then washed out, followed by combing to remove lice and nits. Participants may need to repeat treatment if lice persist, with follow-up over 7 to 10 days. Throughout the study, participants undergo regular assessments including evaluation of lice cure rate by day 10, tolerability checks for skin and eye irritation, and monitoring for any adverse events. Additional evaluations include esthetic properties of the hair on days 0 and 7. Participants are expected to follow study instructions strictly and attend scheduled visits, with overall participation lasting through the 10-day treatment and observation period.

Age: 6Months +All GendersPhase Not Applicable
1 location